SCHEMBL29958623

SCHEMBL29958623

FC(F)Oc1ccc(S)c(N2C=CC=CC2)c1

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.30
CHRNA7 P36544 1/20 0.30
CHRNA4 P43681 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29958355 0.72
SCHEMBL30705391 0.63 TAS2R14 (0.40)
SCHEMBL14596841 0.58 ALOX15 (0.42)
SCHEMBL11065049 0.58 DRD1 (0.56)
SCHEMBL12817707 0.58 POLB (0.42)
SCHEMBL2211626 0.57 DRD1 (0.47)
SCHEMBL9874298 0.56 KCNN4 (0.36)
SCHEMBL6257916 0.56
SCHEMBL28211992 0.56 FAAH (0.42)
SCHEMBL23678581 0.56 DRD1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308122-A1 HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2024-01-24 EP disclosed
CN-116981459-A Heterocyclic derivatives as janus kinase inhibitors 奇斯药制品公司 2023-10-31 CN disclosed
WO-2022194779-A1 HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2022-09-22 WO disclosed